EPIX ESSA Pharma Inc.

Nasdaq essapharma.com


$ 0.20 $ 0.00 (-1.85 %)    

Wednesday, 08-Oct-2025 19:16:18 EDT
QQQ $ 603.18 $ 0.00 (0 %)
DIA $ 465.08 $ 0.00 (0 %)
SPY $ 666.56 $ 0.00 (0 %)
TLT $ 91.00 $ 0.00 (0 %)
GLD $ 386.40 $ 0.00 (0 %)
$ 0.2012
$ 0.20
$ 0.00 x 0
$ 0.00 x 0
-- - --
$ 0.17 - $ 0.83
5,945,141
na
9.52M
$ 1.48
nm
TBD
na
na ($ 8.40)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-11-2025 12-31-2024 10-Q
4 12-17-2024 09-30-2024 10-K
5 08-05-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 02-13-2024 12-31-2023 10-Q
8 12-12-2023 09-30-2023 10-K
9 08-08-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 02-07-2023 12-31-2022 10-Q
12 12-13-2022 09-30-2022 10-K
13 08-04-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 02-03-2022 12-31-2021 10-Q
16 11-18-2021 09-30-2021 10-K
17 08-16-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-11-2021 12-31-2020 10-Q
20 12-15-2020 09-30-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 essa-pharma-received-an-amended-interim-order-from-the-supreme-court-of-british-columbia-on-september-25-2025-the-amended-interim-order-approves-the-previously-announced-date-for-essas-special-meeting-of-the-holders-of-common-shares-of-the-company-optionholders-and-warrantholders-of-october-3-2025

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 30, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Com...

Core News & Articles

Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.1...

 essa-pharma-confirms-80m-capital-distribution-paid-august-22-shares-began-trading-ex-dividend-august-25-after-correcting-due-bill-period

ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ:EPIX) announced on August 14, 2025 that, in connection with...

 essa-pharma-q3-eps-009-beats-016-estimate

ESSA Pharma (NASDAQ:EPIX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.16) b...

 essa-pharma-to-distribute-80m-to-shareholders

SOUTH SAN FRANCISCO, Calif and VANCOUVER, Canada, Aug. 6, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Co...

 essa-pharma-to-seek-court-approval-for-shareholder-payout-and-special-meeting-ahead-of-acquisition-by-xenotherapeutics

 ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ:EPIX) today announced that, in connection with its previou...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION